berberine has been researched along with B16 Melanoma in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Berberine is a natural compound extracted from Coptidis rhizoma, and accumulating proof has shown its potent anti-tumor properties with diverse action on melanoma cells, including inhibiting cancer viability, blocking cell cycle and migration." | 7.83 | Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. ( Du, B; Kou, Y; Li, B; Li, H; Li, L; Tan, Y; Wang, K, 2016) |
| "Berberine is a natural compound extracted from Coptidis rhizoma, and accumulating proof has shown its potent anti-tumor properties with diverse action on melanoma cells, including inhibiting cancer viability, blocking cell cycle and migration." | 3.83 | Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells. ( Du, B; Kou, Y; Li, B; Li, H; Li, L; Tan, Y; Wang, K, 2016) |
| "Berberine has abundant beneficial properties including anti-cancer effects." | 1.48 | Inhibitory effect of berberine from ( Lee, Y; Liu, L; Yi, Y, 2018) |
| "Berberine treatment also decreased various biochemical parameters associated with lung metastasis." | 1.38 | Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. ( Hamsa, TP; Kuttan, G, 2012) |
| "Berberine- and AICAR-treated groups demonstrated significantly decreased lung metastases in the pulmonary metastasis model in vivo." | 1.38 | Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. ( Kim, EJ; Kim, HS; Kim, MJ; Lee, MS; Lim, JS; Yang, Y, 2012) |
| "Berberine could also inhibit endothelial motility, migration, tube formation, and vessel sprouting from rat aortic ring in vitro." | 1.38 | Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. ( Hamsa, TP; Kuttan, G, 2012) |
| "Berberine displays multiphasic effects in these malignant cell lines, which are correlated with the concentration and intracellular distribution of this alkaloid." | 1.35 | Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line. ( Holy, J; Oliveira, PJ; Parke, D; Perkins, E; Sardao, VA; Serafim, TL, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, H | 1 |
| Lin, L | 1 |
| Choi, Y | 1 |
| Michniak-Kohn, B | 1 |
| Lee, Y | 2 |
| Liu, L | 1 |
| Yi, Y | 1 |
| Song, YC | 1 |
| Kim, HM | 1 |
| Hyun, MY | 1 |
| Lim, YY | 1 |
| Song, KY | 1 |
| Kim, BJ | 1 |
| Kou, Y | 1 |
| Li, L | 1 |
| Li, H | 1 |
| Tan, Y | 1 |
| Li, B | 1 |
| Wang, K | 1 |
| Du, B | 1 |
| Hamsa, TP | 2 |
| Kuttan, G | 2 |
| Kim, HS | 1 |
| Kim, MJ | 1 |
| Kim, EJ | 1 |
| Yang, Y | 1 |
| Lee, MS | 1 |
| Lim, JS | 1 |
| Letasiová, S | 1 |
| Jantová, S | 1 |
| Múcková, M | 1 |
| Theiszová, M | 1 |
| Tanabe, H | 1 |
| Suzuki, H | 1 |
| Nagatsu, A | 1 |
| Mizukami, H | 1 |
| Ogihara, Y | 1 |
| Inoue, M | 1 |
| Serafim, TL | 2 |
| Oliveira, PJ | 2 |
| Sardao, VA | 2 |
| Perkins, E | 1 |
| Parke, D | 2 |
| Holy, J | 2 |
| Pereira, GC | 1 |
| Branco, AF | 1 |
| Matos, JA | 1 |
| Pereira, SL | 1 |
| Perkins, EL | 1 |
| Santos, MS | 1 |
| Moreno, AJ | 1 |
11 other studies available for berberine and B16 Melanoma
| Article | Year |
|---|---|
Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma.
Topics: Animals; Berberine; Drug Delivery Systems; Drug Development; Female; Humans; Liposomes; Melanoma, Ex | 2020 |
Inhibitory effect of berberine from
Topics: alpha-MSH; Animals; Berberine; Cell Line, Tumor; Coptis chinensis; Dose-Response Relationship, Drug; | 2018 |
Berberine regulates melanin synthesis by activating PI3K/AKT, ERK and GSK3β in B16F10 melanoma cells.
Topics: Animals; Berberine; Cell Line, Tumor; Cell Survival; Enzyme Activation; Extracellular Signal-Regulat | 2015 |
Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3K/AKT and RARα/RARβ in melanoma cells.
Topics: Animals; Antineoplastic Agents; Berberine; Chromones; Epithelial-Mesenchymal Transition; Gene Expres | 2016 |
Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells.
Topics: Activating Transcription Factor 2; Animals; Antineoplastic Agents, Phytogenic; Berberine; Cell Line, | 2012 |
Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Cell Line, Tumor; Cyclooxygenase 2; Enzyme Activa | 2012 |
Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Topics: Angiogenesis Inhibitors; Animals; Berberine; Cell Line, Tumor; Down-Regulation; Gene Expression Regu | 2012 |
Antiproliferative activity of berberine in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Berberine; Cell Proliferation; Drug Screening Assays, Antitumor; In | 2005 |
Selective inhibition of vascular smooth muscle cell proliferation by coptisine isolated from Coptis rhizoma, one of the crude drugs composing Kampo medicines Unsei-in.
Topics: Animals; Berberine; Cell Cycle; Cell Proliferation; Chromatography, High Pressure Liquid; Coptis; Dr | 2006 |
Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line.
Topics: Animals; Antimetabolites; Berberine; Bromodeoxyuridine; Carbonyl Cyanide p-Trifluoromethoxyphenylhyd | 2008 |
Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions.
Topics: Adenosine Triphosphatases; Animals; Berberine; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhyd | 2007 |